Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05398341 · ClinicalTrials.gov registry record
A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)
A clinical trial of Anterior Cruciate Ligament Injuries, sponsored by Miach Orthopaedics.
- Active
- Registry status
- 300
- Enrollment target
- 9
- Study locations
NCT05398341: Active study of Anterior Cruciate Ligament Injuries, sponsored by Miach Orthopaedics.
NCT05398341 is a study of Anterior Cruciate Ligament Injuries that is active but no longer recruiting, run by Miach Orthopaedics. The registered enrollment target is 300 participants, roughly in line with the 311-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target. The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05398341, a study of Anterior Cruciate Ligament Injuries, is active but no longer recruiting, sponsored by Miach Orthopaedics.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of the Bridge Registry is to assess real-world performance of the FDA approved BEAR Implant.
Primary Outcome
This is a survey patients complete about how their knee is feeling and functioning. Range is 0 to 100, with 100 indicating no problems and 0 indicating extreme problems.
Conditions Studied
Interventions
- DEVICE The BEAR® Implant
Study Locations (9)
New York
- Hospital for Special Surgery - New York
- Victory Sports Medicine - Skaneateles
California
- Stanford - Redwood City
Colorado
- Steamboat Orthopaedic and Spine Institute - Steamboat Springs
Florida
- Advent Health - Orlando
Massachusetts
- Boston Children's Hospital - Boston
New Jersey
- Virtua Health - Marlton
North Carolina
- Duke University - Durham
Oregon
- Oregon Health & Science University (OHSU) - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2027-01-30 |
What the registry record for NCT05398341 still lists
NCT05398341 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 311-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target.
The record links to 1 condition, with Anterior Cruciate Ligament Injuries appearing as the primary indexed condition, and to 1 intervention - of which The BEAR® Implant is the first listed.
NCT05398341 lists 9 locations in 8 states (New York, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT05398341 about?
NCT05398341 is a clinical study titled "A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)". The purpose of the Bridge Registry is to assess real-world performance of the FDA approved BEAR Implant.
What is the current status of trial NCT05398341?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2023-02-28. Estimated completion is 2027-01-30.
What conditions does trial NCT05398341 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Injuries.
What interventions are being tested in trial NCT05398341?
The interventions under investigation include: The BEAR® Implant (DEVICE).
Who is sponsoring clinical trial NCT05398341?
This trial is sponsored by Miach Orthopaedics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05398341 being conducted?
This trial has 9 study locations across California, Colorado, Florida, Massachusetts, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05398341's enrollment target sits among peer trials
300 3rd of 24 higher than 22 of 24 other Anterior Cruciate Ligament Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Anterior Cruciate Ligament Recovery With Virtual Psychological Intervention
RECRUITING · NA
-
Steps Towards Osteoarthritis Prevention
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
-
Dynamic Muscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction in Military Academy Cadets
RECRUITING · NA
-
PRP in ACLR to Prevent PTOA
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI